BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20007805)

  • 21. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SLAT regulates CD8+ T cell clonal expansion in a Cdc42- and NFAT1-dependent manner.
    Feau S; Schoenberger SP; Altman A; Bécart S
    J Immunol; 2013 Jan; 190(1):174-83. PubMed ID: 23197258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Earlier low-dose TBI or DST overcomes CD8+ T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40L.
    Takeuchi Y; Ito H; Kurtz J; Wekerle T; Ho L; Sykes M
    Am J Transplant; 2004 Jan; 4(1):31-40. PubMed ID: 14678032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to ABT-737 in activated T lymphocytes: molecular mechanisms and reversibility by inhibition of the calcineurin-NFAT pathway.
    Cippà PE; Kraus AK; Lindenmeyer MT; Chen J; Guimezanes A; Bardwell PD; Wekerle T; Wüthrich RP; Fehr T
    Cell Death Dis; 2012 Apr; 3(4):e299. PubMed ID: 22513873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of role for CsA-sensitive or Fas pathways in the tolerization of CD4 T cells via BMT and anti-CD40L.
    Kurtz J; Lie A; Griffith M; Eysaman S; Shaffer J; Anosova N; Turka L; Benichou G; Sykes M
    Am J Transplant; 2003 Jul; 3(7):804-16. PubMed ID: 12814472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells.
    Martinez GJ; Pereira RM; Äijö T; Kim EY; Marangoni F; Pipkin ME; Togher S; Heissmeyer V; Zhang YC; Crotty S; Lamperti ED; Ansel KM; Mempel TR; Lähdesmäki H; Hogan PG; Rao A
    Immunity; 2015 Feb; 42(2):265-278. PubMed ID: 25680272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
    Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
    J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cells.
    Fehr T; Wang S; Haspot F; Kurtz J; Blaha P; Hogan T; Chittenden M; Wekerle T; Sykes M
    J Immunol; 2008 Sep; 181(6):4371-80. PubMed ID: 18768896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions.
    Gorbachev AV; Heeger PS; Fairchild RL
    J Immunol; 2001 Feb; 166(4):2323-32. PubMed ID: 11160289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes.
    Joffre O; Gorsse N; Romagnoli P; Hudrisier D; van Meerwijk JP
    Blood; 2004 Jun; 103(11):4216-21. PubMed ID: 14976053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique properties of TCR-activated p38 are necessary for NFAT-dependent T-cell activation.
    Alam MS; Gaida MM; Debnath S; Tagad HD; Miller Jenkins LM; Appella E; Rahman MJ; Ashwell JD
    PLoS Biol; 2018 Jan; 16(1):e2004111. PubMed ID: 29357353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcineurin inhibitors suppress acute graft-versus-host disease via NFAT-independent inhibition of T cell receptor signaling.
    Otsuka S; Melis N; Gaida MM; Dutta D; Weigert R; Ashwell JD
    J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 33822776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirements for induction and maintenance of peripheral tolerance in stringent allograft models.
    Sho M; Kishimoto K; Harada H; Livak M; Sanchez-Fueyo A; Yamada A; Zheng XX; Strom TB; Basadonna GP; Sayegh MH; Rothstein DM
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13230-5. PubMed ID: 16150717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell Proliferation.
    Ayasoufi K; Fan R; Fairchild RL; Valujskikh A
    J Immunol; 2016 Apr; 196(7):3180-90. PubMed ID: 26912319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reciprocal NFAT1 and NFAT2 nuclear localization in CD8+ anergic T cells is regulated by suboptimal calcium signaling.
    Srinivasan M; Frauwirth KA
    J Immunol; 2007 Sep; 179(6):3734-41. PubMed ID: 17785810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
    Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
    Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of alloantigen-primed memory CD4+ and CD8+ T cells by hematopoietic chimerism in mice.
    Lan T; Chen J; Xia J; Wang Y; Xie B; Wang F; Qi Z
    Scand J Immunol; 2010 Aug; 72(2):86-93. PubMed ID: 20618766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration.
    Jones ND; Fluck NC; Roelen DL; Mellor AL; Morris PJ; Wood KJ
    Eur J Immunol; 1997 Jul; 27(7):1591-600. PubMed ID: 9247566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death.
    Wekerle T; Kurtz J; Sayegh M; Ito H; Wells A; Bensinger S; Shaffer J; Turka L; Sykes M
    J Immunol; 2001 Feb; 166(4):2311-6. PubMed ID: 11160287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.